VISUfarma

Eyevance Pharmaceuticals

This company develops and commercialises prescription ophthalmic products to treat ocular surface diseases for ophthalmologists, optometrists and their patients.

Tisbury Pharmaceutical

This company develops drug therapies to treat glaucoma and ocular hypertension for patients with these vision-threatening conditions.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.

VisusNano

This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.

Rheon Medical SA

This company develops adjustable drainage devices and ocular implants for the surgical treatment of glaucoma in patients.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.